Lu-yao Ao

State Key Laboratory Of Natural Medicines, Nanjing 210009, PR China
Puerto Rico

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 8 publications

Corrigendum to "JLX001 Ameliorates ischemia/reperfusion injury by reducing neuronal apoptosis via downregulating JNK signaling pathway" [Neuroscience 418 (2019) 189-204].

Corrigendum to "JLX001 Ameliorates ischemia/reperfusion injury by reducing neuronal apoptosis via downregulating JNK signaling pathway" [Neuroscience 418 (2019) 189-204].

Journal: Neuroscience

Published: June 22, 2025

Therapeutic effects of JLX-001 on ischemic stroke by inducing autophagy via AMPK-ULK1 signaling pathway in rats.

Therapeutic effects of JLX-001 on ischemic stroke by inducing autophagy via AMPK-ULK1 signaling pathway in rats.

Journal: Brain research bulletin

Published: July 08, 2019

Correction: Anti-ulcerogenic effect of KFP-H008 against ethanol-induced gastric ulcer via p38 MAPK/NF-κB pathway.

Correction: Anti-ulcerogenic effect of KFP-H008 against ethanol-induced gastric ulcer via p38 MAPK/NF-κB pathway.

Journal: RSC advances

Published: May 24, 2019

JLX001 Ameliorates Ischemia/Reperfusion Injury by Reducing Neuronal Apoptosis via Down-Regulating JNK Signaling Pathway.

JLX001 Ameliorates Ischemia/Reperfusion Injury by Reducing Neuronal Apoptosis via Down-Regulating JNK Signaling Pathway.

Journal: Neuroscience

Published: April 14, 2019

Immune Cells After Ischemic Stroke Onset: Roles, Migration, and Target Intervention.

Immune Cells After Ischemic Stroke Onset: Roles, Migration, and Target Intervention.

Journal: Journal of molecular neuroscience : MN

Published: July 12, 2018

Therapeutic effects of JLX001 on cerebral ischemia through inhibiting platelet activation and thrombus formation in rats.

Therapeutic effects of JLX001 on cerebral ischemia through inhibiting platelet activation and thrombus formation in rats.

Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie

Published: April 27, 2018

Research progress of mechanisms and drug therapy for neuropathic pain.

Research progress of mechanisms and drug therapy for neuropathic pain.

Journal: Life sciences

Published: June 12, 2017

KFP-H008 blocks gastric acid secretion through inhibiting H+-K+-ATPase.

KFP-H008 blocks gastric acid secretion through inhibiting H+-K+-ATPase.

Journal: European journal of pharmacology

Published: February 27, 2017

Showing 1-8 of 8

Last Updated: 09/26/2026